SPARKLE BYTE LTD 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-20 11:40 am Unchanged | 2022-12-02 | 13D | CASI PHARMACEUTICALS INC CASI | SPARKLE BYTE LTD | 1,019,852 7.600% | 0 (Unchanged) | Filing |